KRAS and pancreatic neoplasm: A KRAS RNA G4 ligand 15a demonstrated its ability to effectively inhibit KRAS protein expression in pancreatic cancer cells (MIA PaCa-2 and PANC-1) without altering the mRNA levels, suggesting that 15a acts as a KRAS translational suppressor [63].